Pierre Kyme - Jun 19, 2024 Form 3 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Stock symbol
ARMP
Transactions as of
Jun 19, 2024
Transactions value $
$0
Form type
3
Date filed
6/28/2024, 06:12 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARMP Common Stock 10K Jun 19, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARMP Stock Options (Right to Buy) Jun 19, 2024 Common Stock 40K $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.